

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 8.47164407 |
| 2 | negative T cell selection (GO:0043383) | 8.42651350 |
| 3 | negative thymic T cell selection (GO:0045060) | 8.00552775 |
| 4 | positive thymic T cell selection (GO:0045059) | 7.99047064 |
| 5 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 7.81255656 |
| 6 | positive T cell selection (GO:0043368) | 7.57273344 |
| 7 | cytidine deamination (GO:0009972) | 7.42088713 |
| 8 | cytidine metabolic process (GO:0046087) | 7.42088713 |
| 9 | cytidine catabolic process (GO:0006216) | 7.42088713 |
| 10 | thymic T cell selection (GO:0045061) | 7.33379729 |
| 11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 7.17377902 |
| 12 | T cell selection (GO:0045058) | 6.88374690 |
| 13 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.88075564 |
| 14 | regulation of gamma-delta T cell activation (GO:0046643) | 6.59438588 |
| 15 | cellular response to interleukin-15 (GO:0071350) | 6.49684511 |
| 16 | T cell receptor signaling pathway (GO:0050852) | 6.34268607 |
| 17 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.18232409 |
| 18 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 6.12179646 |
| 19 | interferon-gamma production (GO:0032609) | 6.12088297 |
| 20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.12049576 |
| 21 | negative regulation of cell killing (GO:0031342) | 6.12049576 |
| 22 | response to interleukin-15 (GO:0070672) | 6.10324573 |
| 23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.00933316 |
| 24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.00933316 |
| 25 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.95077002 |
| 26 | regulation of T cell tolerance induction (GO:0002664) | 5.92730694 |
| 27 | T cell costimulation (GO:0031295) | 5.86022860 |
| 28 | lymphocyte costimulation (GO:0031294) | 5.78140815 |
| 29 | DNA deamination (GO:0045006) | 5.75409783 |
| 30 | leukocyte aggregation (GO:0070486) | 5.59420984 |
| 31 | antigen receptor-mediated signaling pathway (GO:0050851) | 5.47866924 |
| 32 | regulation of T cell receptor signaling pathway (GO:0050856) | 5.40703707 |
| 33 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.28544897 |
| 34 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.03926153 |
| 35 | T cell migration (GO:0072678) | 5.02794704 |
| 36 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.97253922 |
| 37 | positive regulation of tolerance induction (GO:0002645) | 4.81007922 |
| 38 | tolerance induction (GO:0002507) | 4.75540286 |
| 39 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.68019962 |
| 40 | sequestering of actin monomers (GO:0042989) | 4.51687337 |
| 41 | mast cell activation (GO:0045576) | 4.45317993 |
| 42 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.43919860 |
| 43 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.40052707 |
| 44 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.37067791 |
| 45 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.35382884 |
| 46 | positive regulation of B cell differentiation (GO:0045579) | 4.35053791 |
| 47 | regulation of tolerance induction (GO:0002643) | 4.22183090 |
| 48 | regulation of activation of Janus kinase activity (GO:0010533) | 4.13909719 |
| 49 | positive regulation of interleukin-2 production (GO:0032743) | 4.09830828 |
| 50 | negative regulation of viral genome replication (GO:0045071) | 4.03145423 |
| 51 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.95380569 |
| 52 | T cell differentiation (GO:0030217) | 3.94081886 |
| 53 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.89796315 |
| 54 | regulation of response to interferon-gamma (GO:0060330) | 3.86945153 |
| 55 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.82700085 |
| 56 | immunoglobulin mediated immune response (GO:0016064) | 3.81767467 |
| 57 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.80586679 |
| 58 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.80018498 |
| 59 | negative regulation of T cell apoptotic process (GO:0070233) | 3.79649961 |
| 60 | V(D)J recombination (GO:0033151) | 3.79623228 |
| 61 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.77977867 |
| 62 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.77977867 |
| 63 | B cell receptor signaling pathway (GO:0050853) | 3.77569890 |
| 64 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.76916014 |
| 65 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.76717532 |
| 66 | negative regulation of T cell mediated immunity (GO:0002710) | 3.76001868 |
| 67 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.71912900 |
| 68 | T cell activation (GO:0042110) | 3.66187945 |
| 69 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.66067318 |
| 70 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.66067318 |
| 71 | lymphocyte chemotaxis (GO:0048247) | 3.63881552 |
| 72 | lymphocyte migration (GO:0072676) | 3.61976891 |
| 73 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.61478714 |
| 74 | positive regulation of isotype switching (GO:0045830) | 3.61231294 |
| 75 | dendritic cell chemotaxis (GO:0002407) | 3.60540315 |
| 76 | activated T cell proliferation (GO:0050798) | 3.58954033 |
| 77 | regulation of defense response to virus by virus (GO:0050690) | 3.57786959 |
| 78 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.57727426 |
| 79 | regulation of isotype switching (GO:0045191) | 3.54947491 |
| 80 | positive regulation of cell killing (GO:0031343) | 3.52750521 |
| 81 | positive regulation of granulocyte differentiation (GO:0030854) | 3.52512860 |
| 82 | response to type I interferon (GO:0034340) | 3.52373502 |
| 83 | regulation of B cell mediated immunity (GO:0002712) | 3.51563064 |
| 84 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.51078669 |
| 85 | positive regulation of B cell mediated immunity (GO:0002714) | 3.51078669 |
| 86 | mast cell activation involved in immune response (GO:0002279) | 3.50261363 |
| 87 | mast cell degranulation (GO:0043303) | 3.50261363 |
| 88 | natural killer cell activation (GO:0030101) | 3.48403236 |
| 89 | cellular response to type I interferon (GO:0071357) | 3.47766097 |
| 90 | type I interferon signaling pathway (GO:0060337) | 3.47766097 |
| 91 | regulation of regulatory T cell differentiation (GO:0045589) | 3.47208231 |
| 92 | respiratory burst (GO:0045730) | 3.44318066 |
| 93 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.40407517 |
| 94 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.38194410 |
| 95 | regulation of cell killing (GO:0031341) | 3.37866048 |
| 96 | T cell homeostasis (GO:0043029) | 3.36985206 |
| 97 | regulation of B cell differentiation (GO:0045577) | 3.36432103 |
| 98 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.34613177 |
| 99 | positive regulation of humoral immune response (GO:0002922) | 3.33688773 |
| 100 | NIK/NF-kappaB signaling (GO:0038061) | 3.32680967 |
| 101 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.31917998 |
| 102 | chemokine-mediated signaling pathway (GO:0070098) | 3.31916535 |
| 103 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.30592780 |
| 104 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.30528145 |
| 105 | alpha-beta T cell differentiation (GO:0046632) | 3.29152865 |
| 106 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.28840450 |
| 107 | regulation of immunoglobulin production (GO:0002637) | 3.28183048 |
| 108 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.27786098 |
| 109 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.27080798 |
| 110 | Peyers patch development (GO:0048541) | 3.27080798 |
| 111 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.26114874 |
| 112 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.25438772 |
| 113 | B cell mediated immunity (GO:0019724) | 3.25040198 |
| 114 | positive regulation of DNA recombination (GO:0045911) | 3.24282016 |
| 115 | positive regulation of immunoglobulin production (GO:0002639) | 3.23119336 |
| 116 | actin nucleation (GO:0045010) | 3.23075123 |
| 117 | positive regulation of T cell activation (GO:0050870) | 3.22755164 |
| 118 | leukocyte cell-cell adhesion (GO:0007159) | 3.22193527 |
| 119 | alpha-beta T cell activation (GO:0046631) | 3.20121866 |
| 120 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.19731499 |
| 121 | regulation of T cell chemotaxis (GO:0010819) | 3.17595657 |
| 122 | positive regulation of T cell chemotaxis (GO:0010820) | 3.17595657 |
| 123 | regulation of interleukin-2 production (GO:0032663) | 3.16080154 |
| 124 | granulocyte activation (GO:0036230) | 3.15292600 |
| 125 | detection of bacterium (GO:0016045) | 3.14221263 |
| 126 | cellular response to interleukin-4 (GO:0071353) | 3.13340061 |
| 127 | neutrophil activation (GO:0042119) | 3.12944871 |
| 128 | positive regulation of lymphocyte migration (GO:2000403) | 3.11870906 |
| 129 | cellular defense response (GO:0006968) | 3.11485917 |
| 130 | natural killer cell differentiation (GO:0001779) | 3.11094416 |
| 131 | positive regulation of lamellipodium assembly (GO:0010592) | 3.10217066 |
| 132 | heterotypic cell-cell adhesion (GO:0034113) | 3.09212755 |
| 133 | negative regulation of phagocytosis (GO:0050765) | 3.09125997 |
| 134 | regulation of interleukin-4 production (GO:0032673) | 3.07542260 |
| 135 | lymphocyte homeostasis (GO:0002260) | 3.03532880 |
| 136 | dendritic cell migration (GO:0036336) | 3.03297915 |
| 137 | positive regulation of defense response to virus by host (GO:0002230) | 3.01056201 |
| 138 | positive regulation of interleukin-4 production (GO:0032753) | 3.00772407 |
| 139 | positive regulation of T cell mediated immunity (GO:0002711) | 2.99933699 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.69013034 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.14831652 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.75505041 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.26174725 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.68453303 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.64703548 |
| 7 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.58983224 |
| 8 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.57737437 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.55201111 |
| 10 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.55180558 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 3.41594099 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.19270875 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.03969078 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 3.02122262 |
| 15 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.97277108 |
| 16 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.92083613 |
| 17 | * MYB_26560356_Chip-Seq_TH1_Human | 2.81538006 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.70276086 |
| 19 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.46846411 |
| 20 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.32944882 |
| 21 | MAF_26560356_Chip-Seq_TH2_Human | 2.27544427 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.24656033 |
| 23 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.14764459 |
| 24 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.12493461 |
| 25 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.97675090 |
| 26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.95885395 |
| 27 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94413310 |
| 28 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.90910849 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.88094213 |
| 30 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.83429940 |
| 31 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.77767530 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.73811325 |
| 33 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.73147596 |
| 34 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70356835 |
| 35 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68666100 |
| 36 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68617638 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.62498458 |
| 38 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.58934553 |
| 39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.58372609 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57884584 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.54502262 |
| 42 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.49043116 |
| 43 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.47058869 |
| 44 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.46749765 |
| 45 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.45123645 |
| 46 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.43308054 |
| 47 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.43133034 |
| 48 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.42296452 |
| 49 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.38114688 |
| 50 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.36993581 |
| 51 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32247774 |
| 52 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.32099071 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.31440403 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31197558 |
| 55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.28407855 |
| 56 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28210262 |
| 57 | GATA3_26560356_Chip-Seq_TH2_Human | 1.27859882 |
| 58 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.27413631 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20621404 |
| 60 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.16556594 |
| 61 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.16338185 |
| 62 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.12472934 |
| 63 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08572150 |
| 64 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.08543548 |
| 65 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.07605759 |
| 66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07331749 |
| 67 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.07243331 |
| 68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06589461 |
| 69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06073831 |
| 70 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.06028740 |
| 71 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.04761683 |
| 72 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.04189460 |
| 73 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03030767 |
| 74 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00560677 |
| 75 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98846059 |
| 76 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.98266824 |
| 77 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.96676343 |
| 78 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.96197076 |
| 79 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95541183 |
| 80 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94484461 |
| 81 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93028991 |
| 82 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.91847462 |
| 83 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91026293 |
| 84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90207961 |
| 85 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.90204602 |
| 86 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.89267193 |
| 87 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.88753723 |
| 88 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88744047 |
| 89 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.88077982 |
| 90 | * P300_27268052_Chip-Seq_Bcells_Human | 0.87652158 |
| 91 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87630307 |
| 92 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.87507405 |
| 93 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.86953100 |
| 94 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86495840 |
| 95 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.86489519 |
| 96 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.86152781 |
| 97 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85485900 |
| 98 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82880434 |
| 99 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82361958 |
| 100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.82052976 |
| 101 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.81973824 |
| 102 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.81562496 |
| 103 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.80600267 |
| 104 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.80238435 |
| 105 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.80113846 |
| 106 | SA1_27219007_Chip-Seq_Bcells_Human | 0.79725688 |
| 107 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.79390643 |
| 108 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79370711 |
| 109 | GATA3_26560356_Chip-Seq_TH1_Human | 0.78124118 |
| 110 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77325505 |
| 111 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75865822 |
| 112 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.75136489 |
| 113 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.72192851 |
| 114 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71316424 |
| 115 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.70878356 |
| 116 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.70670022 |
| 117 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.68816634 |
| 118 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.66333303 |
| 119 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.65470761 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 6.28701810 |
| 2 | MP0005671_abnormal_response_to | 5.03129622 |
| 3 | MP0000685_abnormal_immune_system | 3.95561687 |
| 4 | MP0002166_altered_tumor_susceptibility | 3.66229960 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.63426362 |
| 6 | MP0001800_abnormal_humoral_immune | 3.36319572 |
| 7 | MP0009333_abnormal_splenocyte_physiolog | 3.09105721 |
| 8 | MP0001790_abnormal_immune_system | 3.05562301 |
| 9 | MP0005387_immune_system_phenotype | 3.05562301 |
| 10 | MP0009785_altered_susceptibility_to | 3.05210056 |
| 11 | MP0002006_tumorigenesis | 2.97350789 |
| 12 | * MP0002398_abnormal_bone_marrow | 2.97187655 |
| 13 | * MP0002420_abnormal_adaptive_immunity | 2.93726825 |
| 14 | * MP0001819_abnormal_immune_cell | 2.91549973 |
| 15 | * MP0005000_abnormal_immune_tolerance | 2.91394900 |
| 16 | * MP0000703_abnormal_thymus_morphology | 2.87005864 |
| 17 | * MP0002723_abnormal_immune_serum | 2.86528396 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.66224947 |
| 19 | MP0006082_CNS_inflammation | 2.59507586 |
| 20 | * MP0000716_abnormal_immune_system | 2.58223870 |
| 21 | MP0005025_abnormal_response_to | 2.56692737 |
| 22 | MP0004947_skin_inflammation | 2.51294821 |
| 23 | MP0002405_respiratory_system_inflammati | 2.49855718 |
| 24 | * MP0002722_abnormal_immune_system | 2.49404452 |
| 25 | MP0000689_abnormal_spleen_morphology | 2.36522771 |
| 26 | MP0003724_increased_susceptibility_to | 2.35837695 |
| 27 | MP0002933_joint_inflammation | 2.25301450 |
| 28 | MP0010155_abnormal_intestine_physiology | 2.25119771 |
| 29 | * MP0002429_abnormal_blood_cell | 2.06991479 |
| 30 | MP0002396_abnormal_hematopoietic_system | 1.98171971 |
| 31 | MP0003866_abnormal_defecation | 1.91929581 |
| 32 | MP0001873_stomach_inflammation | 1.90475428 |
| 33 | MP0004381_abnormal_hair_follicle | 1.87006295 |
| 34 | MP0003436_decreased_susceptibility_to | 1.85614229 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 1.81225936 |
| 36 | MP0004510_myositis | 1.74377441 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.70900442 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.68841968 |
| 39 | MP0002419_abnormal_innate_immunity | 1.67479332 |
| 40 | MP0005310_abnormal_salivary_gland | 1.63345331 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.62492423 |
| 42 | MP0001853_heart_inflammation | 1.43590405 |
| 43 | MP0000858_altered_metastatic_potential | 1.43074578 |
| 44 | MP0002132_abnormal_respiratory_system | 1.34258479 |
| 45 | MP0002009_preneoplasia | 1.33371369 |
| 46 | MP0001851_eye_inflammation | 1.25746778 |
| 47 | MP0002277_abnormal_respiratory_mucosa | 1.15636634 |
| 48 | MP0004808_abnormal_hematopoietic_stem | 1.15160191 |
| 49 | MP0002019_abnormal_tumor_incidence | 1.14677129 |
| 50 | MP0005075_abnormal_melanosome_morpholog | 1.08283965 |
| 51 | MP0008469_abnormal_protein_level | 1.07984886 |
| 52 | MP0002163_abnormal_gland_morphology | 1.06067197 |
| 53 | MP0000490_abnormal_crypts_of | 1.03816188 |
| 54 | MP0003448_altered_tumor_morphology | 1.01811167 |
| 55 | MP0003303_peritoneal_inflammation | 0.98297262 |
| 56 | MP0001533_abnormal_skeleton_physiology | 0.90659703 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 0.88859726 |
| 58 | MP0005166_decreased_susceptibility_to | 0.86295516 |
| 59 | MP0002998_abnormal_bone_remodeling | 0.85228574 |
| 60 | MP0001348_abnormal_lacrimal_gland | 0.79268730 |
| 61 | MP0008057_abnormal_DNA_replication | 0.79223566 |
| 62 | MP0001919_abnormal_reproductive_system | 0.76715107 |
| 63 | MP0003646_muscle_fatigue | 0.73527247 |
| 64 | MP0010094_abnormal_chromosome_stability | 0.72391015 |
| 65 | MP0001545_abnormal_hematopoietic_system | 0.71752283 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 0.71752283 |
| 67 | MP0010234_abnormal_vibrissa_follicle | 0.71676169 |
| 68 | MP0009763_increased_sensitivity_to | 0.71328583 |
| 69 | MP0002138_abnormal_hepatobiliary_system | 0.68771146 |
| 70 | MP0003077_abnormal_cell_cycle | 0.68285356 |
| 71 | MP0005023_abnormal_wound_healing | 0.67916703 |
| 72 | MP0001663_abnormal_digestive_system | 0.66998993 |
| 73 | MP0001243_abnormal_dermal_layer | 0.62298108 |
| 74 | MP0002822_catalepsy | 0.61537211 |
| 75 | MP0000477_abnormal_intestine_morphology | 0.60628950 |
| 76 | MP0003183_abnormal_peptide_metabolism | 0.60211603 |
| 77 | MP0002095_abnormal_skin_pigmentation | 0.59889332 |
| 78 | MP0003045_fibrosis | 0.59095376 |
| 79 | MP0003786_premature_aging | 0.57778081 |
| 80 | MP0009765_abnormal_xenobiotic_induced | 0.57145282 |
| 81 | MP0008260_abnormal_autophagy | 0.56980892 |
| 82 | MP0009764_decreased_sensitivity_to | 0.56111064 |
| 83 | MP0001191_abnormal_skin_condition | 0.53702099 |
| 84 | MP0002136_abnormal_kidney_physiology | 0.53361720 |
| 85 | MP0004883_abnormal_blood_vessel | 0.52974012 |
| 86 | MP0004957_abnormal_blastocyst_morpholog | 0.52799556 |
| 87 | MP0002693_abnormal_pancreas_physiology | 0.52728284 |
| 88 | MP0008873_increased_physiological_sensi | 0.51628744 |
| 89 | MP0001986_abnormal_taste_sensitivity | 0.51468595 |
| 90 | MP0000609_abnormal_liver_physiology | 0.51239118 |
| 91 | MP0003795_abnormal_bone_structure | 0.50017915 |
| 92 | MP0001216_abnormal_epidermal_layer | 0.49183411 |
| 93 | MP0010352_gastrointestinal_tract_polyps | 0.48270663 |
| 94 | MP0005645_abnormal_hypothalamus_physiol | 0.46840174 |
| 95 | MP0000604_amyloidosis | 0.45730851 |
| 96 | MP0003693_abnormal_embryo_hatching | 0.45340916 |
| 97 | MP0009643_abnormal_urine_homeostasis | 0.45194754 |
| 98 | MP0005390_skeleton_phenotype | 0.44354100 |
| 99 | MP0005451_abnormal_body_composition | 0.44264746 |
| 100 | MP0008058_abnormal_DNA_repair | 0.43696805 |
| 101 | MP0000313_abnormal_cell_death | 0.43471382 |
| 102 | MP0005174_abnormal_tail_pigmentation | 0.42055731 |
| 103 | MP0005076_abnormal_cell_differentiation | 0.41568807 |
| 104 | MP0003453_abnormal_keratinocyte_physiol | 0.41380747 |
| 105 | MP0000367_abnormal_coat/_hair | 0.41133897 |
| 106 | MP0005379_endocrine/exocrine_gland_phen | 0.40060521 |
| 107 | MP0002168_other_aberrant_phenotype | 0.39609274 |
| 108 | MP0002083_premature_death | 0.38893843 |
| 109 | MP0009278_abnormal_bone_marrow | 0.38790918 |
| 110 | MP0008961_abnormal_basal_metabolism | 0.38340987 |
| 111 | MP0003191_abnormal_cellular_cholesterol | 0.38234336 |
| 112 | MP0008874_decreased_physiological_sensi | 0.37931847 |
| 113 | MP0009642_abnormal_blood_homeostasis | 0.36664573 |
| 114 | MP0008569_lethality_at_weaning | 0.36131264 |
| 115 | MP0003111_abnormal_nucleus_morphology | 0.35905915 |
| 116 | MP0003279_aneurysm | 0.35499912 |
| 117 | MP0000249_abnormal_blood_vessel | 0.35475029 |
| 118 | MP0008007_abnormal_cellular_replicative | 0.35137332 |
| 119 | MP0003075_altered_response_to | 0.34821543 |
| 120 | MP0003787_abnormal_imprinting | 0.34333189 |
| 121 | MP0001765_abnormal_ion_homeostasis | 0.34163496 |
| 122 | MP0000372_irregular_coat_pigmentation | 0.33473154 |
| 123 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.33302366 |
| 124 | MP0003806_abnormal_nucleotide_metabolis | 0.33229372 |
| 125 | MP0009931_abnormal_skin_appearance | 0.32999827 |
| 126 | MP0002877_abnormal_melanocyte_morpholog | 0.32261326 |
| 127 | MP0000920_abnormal_myelination | 0.32030357 |
| 128 | MP0000343_altered_response_to | 0.31618439 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 8.28716699 |
| 2 | Abnormality of T cell number (HP:0011839) | 8.14394454 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 7.21968362 |
| 4 | Combined immunodeficiency (HP:0005387) | 6.74045577 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.82571371 |
| 6 | Recurrent bronchitis (HP:0002837) | 5.72555775 |
| 7 | Abnormality of T cells (HP:0002843) | 5.71941473 |
| 8 | Autoimmune hemolytic anemia (HP:0001890) | 5.70687123 |
| 9 | IgG deficiency (HP:0004315) | 5.55131821 |
| 10 | Thyroiditis (HP:0100646) | 5.47320037 |
| 11 | Stomatitis (HP:0010280) | 5.27184217 |
| 12 | B lymphocytopenia (HP:0010976) | 5.25522922 |
| 13 | Abnormality of B cell number (HP:0010975) | 5.25522922 |
| 14 | Abnormality of macrophages (HP:0004311) | 4.79880424 |
| 15 | Hypoplasia of the thymus (HP:0000778) | 4.79337653 |
| 16 | IgM deficiency (HP:0002850) | 4.78943392 |
| 17 | Abnormality of eosinophils (HP:0001879) | 4.67789484 |
| 18 | Panhypogammaglobulinemia (HP:0003139) | 4.61013692 |
| 19 | Recurrent fungal infections (HP:0002841) | 4.51252111 |
| 20 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.49813566 |
| 21 | Recurrent cutaneous fungal infections (HP:0011370) | 4.49813566 |
| 22 | Increased IgM level (HP:0003496) | 4.47119721 |
| 23 | Recurrent viral infections (HP:0004429) | 4.31527868 |
| 24 | Eosinophilia (HP:0001880) | 4.27721819 |
| 25 | Lymphopenia (HP:0001888) | 4.19354292 |
| 26 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.14122937 |
| 27 | Aplastic anemia (HP:0001915) | 3.88047787 |
| 28 | Agammaglobulinemia (HP:0004432) | 3.82870220 |
| 29 | Leukocytosis (HP:0001974) | 3.79912904 |
| 30 | Chronic otitis media (HP:0000389) | 3.78081598 |
| 31 | Chronic diarrhea (HP:0002028) | 3.76459053 |
| 32 | Myositis (HP:0100614) | 3.67164989 |
| 33 | Granulocytopenia (HP:0001913) | 3.63535380 |
| 34 | Nasal polyposis (HP:0100582) | 3.60716404 |
| 35 | Eczematoid dermatitis (HP:0000976) | 3.49333249 |
| 36 | Abnormality of T cell physiology (HP:0011840) | 3.48440760 |
| 37 | Recurrent sinusitis (HP:0011108) | 3.45033903 |
| 38 | Pustule (HP:0200039) | 3.43493304 |
| 39 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.25154653 |
| 40 | Meningitis (HP:0001287) | 3.23456400 |
| 41 | Bronchitis (HP:0012387) | 3.18027576 |
| 42 | Joint swelling (HP:0001386) | 3.12554733 |
| 43 | Abnormality of the fingertips (HP:0001211) | 3.06836878 |
| 44 | Abnormality of the nasal mucosa (HP:0000433) | 3.04409596 |
| 45 | Recurrent otitis media (HP:0000403) | 3.01136221 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.00751515 |
| 47 | Autoimmune thrombocytopenia (HP:0001973) | 2.94325194 |
| 48 | Lymphoma (HP:0002665) | 2.91531923 |
| 49 | Hypergammaglobulinemia (HP:0010702) | 2.84488369 |
| 50 | Colitis (HP:0002583) | 2.78270345 |
| 51 | IgA deficiency (HP:0002720) | 2.77353336 |
| 52 | Chest pain (HP:0100749) | 2.74994070 |
| 53 | Verrucae (HP:0200043) | 2.74598497 |
| 54 | Papilloma (HP:0012740) | 2.74598497 |
| 55 | Vasculitis (HP:0002633) | 2.74157300 |
| 56 | Acute hepatic failure (HP:0006554) | 2.70460794 |
| 57 | Recurrent skin infections (HP:0001581) | 2.64325062 |
| 58 | Urticaria (HP:0001025) | 2.63848800 |
| 59 | Recurrent abscess formation (HP:0002722) | 2.62682369 |
| 60 | Basal cell carcinoma (HP:0002671) | 2.57163956 |
| 61 | Hypoproteinemia (HP:0003075) | 2.54477679 |
| 62 | Hemoptysis (HP:0002105) | 2.49335526 |
| 63 | Mediastinal lymphadenopathy (HP:0100721) | 2.48653883 |
| 64 | Chronic obstructive pulmonary disease (HP:0006510) | 2.44918105 |
| 65 | Obstructive lung disease (HP:0006536) | 2.44918105 |
| 66 | Chronic sinusitis (HP:0011109) | 2.43809154 |
| 67 | Retrobulbar optic neuritis (HP:0100654) | 2.39661231 |
| 68 | Optic neuritis (HP:0100653) | 2.39661231 |
| 69 | Hypochromic anemia (HP:0001931) | 2.39597908 |
| 70 | Gangrene (HP:0100758) | 2.37077801 |
| 71 | Pulmonary infiltrates (HP:0002113) | 2.34426404 |
| 72 | Gastrointestinal infarctions (HP:0005244) | 2.34001598 |
| 73 | Encephalitis (HP:0002383) | 2.33015108 |
| 74 | Abnormality of the pleura (HP:0002103) | 2.28317985 |
| 75 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.28048724 |
| 76 | Hemiplegia (HP:0002301) | 2.23911962 |
| 77 | Orchitis (HP:0100796) | 2.21272684 |
| 78 | Gastrointestinal inflammation (HP:0004386) | 2.21023561 |
| 79 | Inflammation of the large intestine (HP:0002037) | 2.19349158 |
| 80 | Gastrointestinal stroma tumor (HP:0100723) | 2.09970417 |
| 81 | Thrombocytosis (HP:0001894) | 2.07837205 |
| 82 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.03617591 |
| 83 | Spontaneous hematomas (HP:0007420) | 2.02106228 |
| 84 | Cheilitis (HP:0100825) | 2.00983904 |
| 85 | Hypochromic microcytic anemia (HP:0004840) | 2.00427686 |
| 86 | Restrictive lung disease (HP:0002091) | 1.99695222 |
| 87 | Sepsis (HP:0100806) | 1.99521286 |
| 88 | Skin rash (HP:0000988) | 1.98783945 |
| 89 | Abnormality of the prostate (HP:0008775) | 1.97700319 |
| 90 | Poikiloderma (HP:0001029) | 1.96490133 |
| 91 | Bronchiectasis (HP:0002110) | 1.94134387 |
| 92 | Increased IgE level (HP:0003212) | 1.92944753 |
| 93 | Keratoconjunctivitis sicca (HP:0001097) | 1.91669955 |
| 94 | Premature loss of primary teeth (HP:0006323) | 1.88614028 |
| 95 | Keratoconjunctivitis (HP:0001096) | 1.86263840 |
| 96 | Cellulitis (HP:0100658) | 1.85886314 |
| 97 | Anorexia (HP:0002039) | 1.84578413 |
| 98 | Skin ulcer (HP:0200042) | 1.82306170 |
| 99 | Episodic fever (HP:0001954) | 1.81777633 |
| 100 | Emphysema (HP:0002097) | 1.79161067 |
| 101 | Osteomyelitis (HP:0002754) | 1.79103786 |
| 102 | Recurrent bacterial skin infections (HP:0005406) | 1.75319586 |
| 103 | Amyotrophic lateral sclerosis (HP:0007354) | 1.75246515 |
| 104 | Abnormality of the thymus (HP:0000777) | 1.73313011 |
| 105 | Entropion (HP:0000621) | 1.72238360 |
| 106 | Ureteral stenosis (HP:0000071) | 1.71423728 |
| 107 | Arterial thrombosis (HP:0004420) | 1.70418504 |
| 108 | Hepatitis (HP:0012115) | 1.67954128 |
| 109 | Epistaxis (HP:0000421) | 1.67893629 |
| 110 | Pulmonary embolism (HP:0002204) | 1.67535669 |
| 111 | Gingivitis (HP:0000230) | 1.67335191 |
| 112 | Cellular immunodeficiency (HP:0005374) | 1.65651277 |
| 113 | Petechiae (HP:0000967) | 1.64769186 |
| 114 | Amaurosis fugax (HP:0100576) | 1.63248324 |
| 115 | Muscle fiber atrophy (HP:0100295) | 1.62340176 |
| 116 | Arthralgia (HP:0002829) | 1.60159073 |
| 117 | Microcytic anemia (HP:0001935) | 1.58888516 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.34326478 |
| 2 | MAP4K1 | 5.83951732 |
| 3 | ZAP70 | 3.60453701 |
| 4 | ITK | 3.29090047 |
| 5 | RIPK4 | 3.28999915 |
| 6 | FGFR4 | 3.25566430 |
| 7 | IKBKE | 2.95541762 |
| 8 | KDR | 2.77480225 |
| 9 | JAK3 | 2.66992961 |
| 10 | GRK6 | 2.45633306 |
| 11 | TYK2 | 2.45493568 |
| 12 | STK10 | 2.24973574 |
| 13 | LCK | 2.15376081 |
| 14 | TESK2 | 2.14170675 |
| 15 | MAP3K10 | 2.07568624 |
| 16 | MAP3K11 | 2.02396803 |
| 17 | JAK1 | 2.00975551 |
| 18 | NLK | 1.93596453 |
| 19 | SYK | 1.93310657 |
| 20 | TBK1 | 1.92516297 |
| 21 | FGFR3 | 1.89836868 |
| 22 | TEC | 1.79079131 |
| 23 | MST4 | 1.77473798 |
| 24 | BLK | 1.75090600 |
| 25 | MAP3K14 | 1.68854279 |
| 26 | BTK | 1.68497841 |
| 27 | CSK | 1.51744279 |
| 28 | HCK | 1.50822358 |
| 29 | PRPF4B | 1.40608832 |
| 30 | NME2 | 1.38678400 |
| 31 | BCKDK | 1.31818973 |
| 32 | EEF2K | 1.24413694 |
| 33 | TAOK3 | 1.23325176 |
| 34 | PRKCH | 1.23009459 |
| 35 | LRRK2 | 1.20505420 |
| 36 | PRKCQ | 1.15381169 |
| 37 | KIT | 1.08599033 |
| 38 | MAP3K12 | 1.08138483 |
| 39 | MAP3K13 | 1.06023884 |
| 40 | TLK1 | 1.00777246 |
| 41 | LYN | 0.97885340 |
| 42 | TNK2 | 0.95111809 |
| 43 | IKBKB | 0.92684396 |
| 44 | CAMKK1 | 0.87923731 |
| 45 | CAMKK2 | 0.87870783 |
| 46 | CLK1 | 0.86362664 |
| 47 | PIK3CG | 0.86200548 |
| 48 | SCYL2 | 0.81005423 |
| 49 | IRAK4 | 0.74420797 |
| 50 | PKN2 | 0.72827001 |
| 51 | MARK3 | 0.70062204 |
| 52 | BRD4 | 0.68081506 |
| 53 | EPHB1 | 0.67784542 |
| 54 | FYN | 0.67105482 |
| 55 | CSF1R | 0.66087704 |
| 56 | ERN1 | 0.65866873 |
| 57 | VRK1 | 0.65788271 |
| 58 | SIK2 | 0.65763725 |
| 59 | JAK2 | 0.65676181 |
| 60 | PIM1 | 0.64337313 |
| 61 | FES | 0.62638424 |
| 62 | TESK1 | 0.62462764 |
| 63 | FGR | 0.61881814 |
| 64 | INSR | 0.61670413 |
| 65 | CHUK | 0.61431912 |
| 66 | MAPK11 | 0.61411541 |
| 67 | GRK7 | 0.59586016 |
| 68 | MAP3K7 | 0.58776888 |
| 69 | FGFR1 | 0.57719062 |
| 70 | CDK4 | 0.52610693 |
| 71 | LIMK1 | 0.52401216 |
| 72 | SIK3 | 0.51684488 |
| 73 | PDGFRB | 0.51582477 |
| 74 | SMG1 | 0.50206348 |
| 75 | MAPKAPK3 | 0.49821792 |
| 76 | TGFBR2 | 0.47841887 |
| 77 | STK4 | 0.47651933 |
| 78 | MAP2K3 | 0.46292469 |
| 79 | FGFR2 | 0.45879529 |
| 80 | MAP3K1 | 0.43985288 |
| 81 | RPS6KA4 | 0.43750606 |
| 82 | IGF1R | 0.42197779 |
| 83 | MARK2 | 0.41054377 |
| 84 | BMPR2 | 0.40277381 |
| 85 | MAPK7 | 0.40259569 |
| 86 | TAOK2 | 0.40153902 |
| 87 | PASK | 0.39861304 |
| 88 | PDK1 | 0.39119453 |
| 89 | EIF2AK1 | 0.39088603 |
| 90 | HIPK2 | 0.38963176 |
| 91 | ADRBK2 | 0.36716452 |
| 92 | MAPK12 | 0.36423547 |
| 93 | DYRK1B | 0.35070917 |
| 94 | MAP2K6 | 0.34811826 |
| 95 | RPS6KB2 | 0.34778133 |
| 96 | NEK2 | 0.34422338 |
| 97 | EIF2AK3 | 0.33065277 |
| 98 | CDK12 | 0.31831560 |
| 99 | VRK2 | 0.31754125 |
| 100 | PRKD2 | 0.30910045 |
| 101 | TYRO3 | 0.30828122 |
| 102 | DAPK1 | 0.30288013 |
| 103 | MAPK4 | 0.30200852 |
| 104 | MAPK3 | 0.28434295 |
| 105 | AURKA | 0.27501624 |
| 106 | ILK | 0.27396894 |
| 107 | STK16 | 0.27005166 |
| 108 | MAP3K3 | 0.26608115 |
| 109 | PRKCD | 0.25580848 |
| 110 | CSNK1G3 | 0.24270749 |
| 111 | CDK9 | 0.24017616 |
| 112 | TGFBR1 | 0.23986277 |
| 113 | CSNK1A1L | 0.23176971 |
| 114 | TAOK1 | 0.22160144 |
| 115 | CSNK1G1 | 0.22055248 |
| 116 | RPS6KA5 | 0.20950265 |
| 117 | ABL1 | 0.19452693 |
| 118 | MELK | 0.18898039 |
| 119 | SRC | 0.18882331 |
| 120 | MAP3K5 | 0.18673402 |
| 121 | ALK | 0.17521146 |
| 122 | EPHA3 | 0.17476423 |
| 123 | MYLK | 0.17302314 |
| 124 | ZAK | 0.17240484 |
| 125 | CDC7 | 0.16619726 |
| 126 | PRKCB | 0.16583758 |
| 127 | CDC42BPA | 0.16281007 |
| 128 | PDPK1 | 0.16007006 |
| 129 | MAPKAPK2 | 0.15420079 |
| 130 | MAP3K8 | 0.14475279 |
| 131 | SIK1 | 0.13514791 |
| 132 | RPS6KA6 | 0.13037611 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 7.72834909 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.24545910 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.39247060 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.11736247 |
| 5 | Measles_Homo sapiens_hsa05162 | 3.09266090 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.93003623 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.74012772 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.71346490 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.64478596 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.58084185 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.37448444 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.96905296 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.85450288 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.77659654 |
| 15 | Ribosome_Homo sapiens_hsa03010 | 1.74864498 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.69461198 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.69056381 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.67411729 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.67132570 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.49523100 |
| 21 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.48988126 |
| 22 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.38660142 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.34160909 |
| 24 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.31647532 |
| 25 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27467602 |
| 26 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.24951731 |
| 27 | Shigellosis_Homo sapiens_hsa05131 | 1.20528581 |
| 28 | HTLV-I infection_Homo sapiens_hsa05166 | 1.15808012 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.15247718 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.06863797 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.06206750 |
| 32 | Hepatitis B_Homo sapiens_hsa05161 | 1.05159427 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98175902 |
| 34 | Spliceosome_Homo sapiens_hsa03040 | 0.96324168 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 0.94853098 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 0.92330106 |
| 37 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.89773682 |
| 38 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86671486 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.85128233 |
| 40 | DNA replication_Homo sapiens_hsa03030 | 0.82481289 |
| 41 | Proteasome_Homo sapiens_hsa03050 | 0.81526856 |
| 42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81322661 |
| 43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80812021 |
| 44 | Mismatch repair_Homo sapiens_hsa03430 | 0.80476735 |
| 45 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.77574458 |
| 46 | Alcoholism_Homo sapiens_hsa05034 | 0.77316930 |
| 47 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76312229 |
| 48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.75702935 |
| 49 | Colorectal cancer_Homo sapiens_hsa05210 | 0.74949036 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.73725423 |
| 51 | Asthma_Homo sapiens_hsa05310 | 0.73282420 |
| 52 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.72754919 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70877029 |
| 54 | Base excision repair_Homo sapiens_hsa03410 | 0.68737782 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.67187498 |
| 56 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.66451251 |
| 57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65105368 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.64964851 |
| 59 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62904360 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60566394 |
| 61 | Phagosome_Homo sapiens_hsa04145 | 0.59130326 |
| 62 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.58665621 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 0.57076980 |
| 64 | Tuberculosis_Homo sapiens_hsa05152 | 0.56444067 |
| 65 | Legionellosis_Homo sapiens_hsa05134 | 0.56084116 |
| 66 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.50595170 |
| 67 | Malaria_Homo sapiens_hsa05144 | 0.49181077 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47120876 |
| 69 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46098710 |
| 70 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.45538798 |
| 71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.44505803 |
| 72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44210735 |
| 73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40780997 |
| 74 | RNA degradation_Homo sapiens_hsa03018 | 0.40524217 |
| 75 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.40485188 |
| 76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39605508 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.39564249 |
| 78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.39308714 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.35634761 |
| 80 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.35322765 |
| 81 | Adherens junction_Homo sapiens_hsa04520 | 0.31728596 |
| 82 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31576947 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.29046035 |
| 84 | Thyroid cancer_Homo sapiens_hsa05216 | 0.28946387 |
| 85 | RNA polymerase_Homo sapiens_hsa03020 | 0.27865613 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.27773890 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.27644053 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27346080 |
| 89 | Homologous recombination_Homo sapiens_hsa03440 | 0.27284748 |
| 90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.27108422 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26980491 |
| 92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26151750 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25186023 |
| 94 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.24768195 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.21616333 |
| 96 | Pertussis_Homo sapiens_hsa05133 | 0.20587395 |
| 97 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.20296919 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19925745 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.19421048 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | 0.18881773 |
| 101 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.18121189 |
| 102 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.17486085 |
| 103 | Cell cycle_Homo sapiens_hsa04110 | 0.16701489 |
| 104 | Basal transcription factors_Homo sapiens_hsa03022 | 0.16579267 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.12784563 |
| 106 | Pathways in cancer_Homo sapiens_hsa05200 | 0.12129518 |
| 107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.11321992 |
| 108 | RNA transport_Homo sapiens_hsa03013 | 0.11237012 |
| 109 | Endometrial cancer_Homo sapiens_hsa05213 | 0.10790518 |
| 110 | Parkinsons disease_Homo sapiens_hsa05012 | 0.10637279 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.10330288 |
| 112 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.10080684 |
| 113 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.09164857 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.08616524 |
| 115 | Sulfur relay system_Homo sapiens_hsa04122 | 0.07908876 |
| 116 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.02986543 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.02919358 |
| 118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.02215561 |
| 119 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.01781215 |
| 120 | Long-term potentiation_Homo sapiens_hsa04720 | 0.01038468 |
| 121 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0419713 |
| 122 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.0164615 |
| 123 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0115271 |
| 124 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.0050637 |

